Itsumaro Kumadaki Selected Research

alpha tocotrienol

1/2008	A redox-silent analogue of tocotrienol inhibits hypoxic adaptation of lung cancer cells.
7/2005	Induction of cytotoxicity in human lung adenocarcinoma cells by 6-O-carboxypropyl-alpha-tocotrienol, a redox-silent derivative of alpha-tocotrienol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Itsumaro Kumadaki Research Topics

Disease

2	Neoplasms (Cancer) 01/2008 - 11/2003
1	Hypoxia (Hypoxemia) 01/2008
1	Lung Neoplasms (Lung Cancer) 01/2008
1	Adenocarcinoma of Lung 07/2005
1	Breast Neoplasms (Breast Cancer) 11/2003

Drug/Important Bio-Agent (IBA)

2	alpha tocotrienolIBA 01/2008 - 07/2005
2	6-O-carboxypropyl-alpha-tocotrienolIBA 01/2008 - 07/2005
1	TocotrienolsIBA 01/2008
1	PlasminogenIBA 01/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2008
1	alpha-Tocopherol FDA Link 07/2005
1	Antineoplastic Agents (Antineoplastics)IBA 07/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2003
1	tocopheryloxybutyric acidIBA 11/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 11/2003